T CELL SCIENCES, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C07K PEPTIDES 2134
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194
 
  
 
B01D SEPARATION 1133

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
5858969 Therapeutic methods employing sialylated glycoforms of soluble complement receptor 1 (SCR 1)Jun 06, 95Jan 12, 99[A61K]
5856297 Human C3b/C4b receptor (CR1)Jun 06, 95Jan 05, 99[A01N, C07K]
5840858 Protein purification using immobilized metal affinity chromatography for complement receptor proteinsApr 03, 96Nov 24, 98[C07K]
5472939 Method of treating complement mediated disordersOct 19, 93Dec 05, 95[A61K]
5456909 Glycoform fractions of recombinant soluble complement receptor 1 (sCR1) having extended half-lives in vivoAug 07, 92Oct 10, 95[A61K]
5252216 Protein purificationMar 24, 92Oct 12, 93[B01D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
6555113 Modulation of cholesteryl ester transfer protein (CETP) activityExpiredOct 17, 97Apr 29, 03[A61K]
6410022 Modulation of cholesteryl ester transfer protein (CETP) activityExpiredMay 01, 95Jun 25, 02[A61K, C07K]
6284533 Plasmid-based vaccine for treating atherosclerosisExpiredOct 02, 98Sep 04, 01[A61K, C12N]
6193979 Compositions comprising complement receptor type 1 molecules having carbohydrate structures that are selectin ligandsExpiredMay 25, 95Feb 27, 01[A61K]
6169068 Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivativesExpiredAug 11, 95Jan 02, 01[A61K]
5976540 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositionsExpiredApr 16, 98Nov 02, 99[A61K]
5958410 Therapy of sarcoidosisExpiredNov 06, 95Sep 28, 99[A61K, C07K]
5856300 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositionsExpiredNov 13, 95Jan 05, 99[A61K, C12P, G01N, C07K]
5808109 Compounds that inhibit complement and/or suppress immune activityExpiredJun 07, 95Sep 15, 98[C07D]
5656659 Compounds which inhibit complement and/or suppress immune activityExpiredNov 18, 94Aug 12, 97[A61K]
5506247 Compounds that inhibit complement and/or suppress immune activityExpiredJan 21, 94Apr 09, 96[A61K, C07D]
5401767 Compounds which inhibit complement and/or suppress immune activityExpiredDec 21, 92Mar 28, 95[A61K]
5366986 Compounds which inhibit complement and/or suppress immune activityExpiredDec 06, 90Nov 22, 94[A61K, C07D]
5256642 Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereofExpiredSep 24, 90Oct 26, 93[A61K, C12N, C07K]
5212071 Nucleic acids encoding a human C3b/C4b receptor (CR1)ExpiredApr 03, 89May 18, 93[C12N]
5173499 Compounds which inhibit complement and/or suppress immune activityExpiredApr 15, 88Dec 22, 92[A61K, C07D]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.